ClinOption ApS: Financial statements 2024
CVR: 42731323
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ClinOption ApS (CVR 42731323) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,807,757 and a net result of DKK 725,678 compared with DKK 508,086 the year before. That is a decrease of 1.5% compared with the year before. Equity in the 2024 report amounted to DKK 493,163. The solvency ratio was 43.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,807,757
- Profit/Loss
- DKK 725,678
- Equity
- DKK 493,163
- Total Assets
- DKK 1,125,331
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.8 mio. | 726 t. | 493 t. | 1 |
| 2023 | - | 1.8 mio. | 508 t. | 627 t. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ClinOption ApS has published its annual report for 2023. Gross profit came to DKK 1,834,983, and the net result was DKK 508,086.
About ClinOption ApS
ClinOption ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tim Dehli Carstensen. The company is owned by Titi14 HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,583,668 and a net result of DKK 414,793 compared with DKK 725,678 the year before. Equity in the 2025 report amounted to DKK 557,956.